1-5 of 5
Piera Viero
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol

Free
Alessandra Romano, MDPhD, Francesco Di Raimondo, MD, Chiara Pavoni, Statistician, Corrado Tarella, MD Prof, Simonetta Viviani, MD, Andrea Rossi, MD, Caterina Patti, Marco Picardi, MD, Maria Cantonetti, MD, Giorgio La Nasa, MD, Livio Trentin, MD, Silvia Bolis, MD, Valerio Zoli, Paolo Gavarotti, Paolo Corradini, MD, Michele Cimminiello, MD PhD, Corrado Schiavotto, Guido Eugenio Parvis, Roberta Zanotti, MD, Guido Gini, MD, Andres J M Ferreri, MD, Piera Viero, Alberto Biggi, Alessandro M. Gianni, MD Prof, Andrea Gallamini, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2934.
https://doi.org/10.1182/blood-2018-99-115346
Published: 2018
Journal Articles

Global Phase I/III Pharmacokinetic and Efficacy Study Comparing CT-P10, a Biosimilar Candidate to the Rituximab Reference Product in Patients with Advanced Stage Follicular Lymphoma (AFL)

Free
Won Seog Kim, Michinori Ogura, Christian Buske, Bertrand Coiffier, Juan-Manuel Sancho, Wojciech Jurczak, Jin Seok Kim, Raj V Nagarkar, Edvard Zhavrid, Jose Angel Hernandez Rivas, Yuriy Vinnyk, Panagiotis Tsirigotis, Piera Viero, Elena Volodicheva, Samuel Fourie, Juan Soler
Journal: Blood
Blood (2015) 126 (23): 5111.
https://doi.org/10.1182/blood.V126.23.5111.5111
Published: 2015
Journal Articles

Multicentric Clinical Audit of Chemotherapy Administration for Lymphoprolipherative Diseases in Day Hospital Patient Setting

Free
Giuliana Emilia Muti, MD, Chiara Rusconi, MD, Anna Brizio, MD, Mauro Turrini, MD, Piera Viero, MD, Carmela Iazzetta, Michela Terzi, Claudia Vener, MD, Consuelo Corti, MD, Fabio Giglio, MD, Morena Nazzari, MD, Cristina Fiamenghi, Enrica Morra, MD
Journal: Blood
Blood (2008) 112 (11): 4712.
https://doi.org/10.1182/blood.V112.11.4712.4712
Published: 2008
Journal Articles

The Addition of Rituximab to High Dose Sequential Chemotherapy (HDS) Programs with Autologous Transplantation Significantly Improves the Outcome of Patients with Refractory or Relapsed B-Cell Non Hogkin’s Lymphoma.

Free
Sergio Cortelazzo, MD, Andrea Rossi, MD, Emanuela Carlotti, BSc, Piera Viero, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD
Journal: Blood
Blood (2005) 106 (11): 2084.
https://doi.org/10.1182/blood.V106.11.2084.2084
Published: 2005
Journal Articles

Time- and Dose-Response Relationships of Imatinib Mesylate (Glivec) Therapy for Chronic Hypereosinophilic Syndromes.

Free
Renato Bassan, MD, Sara Acerboni, BSc, Silvia Mappa, MD, Piera Viero, MD, Federica Delaini, BSc, Giuseppe Rossi, Valentina Rossi, A. Vannucchi, MD, Eros Di Bona, MD, Emanuela Ruggeri, Anna Salvi, Ursula Giussani, BSc, Francesca Rancati, MD, Tamara Intermesoli, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD
Journal: Blood
Blood (2005) 106 (11): 2596.
https://doi.org/10.1182/blood.V106.11.2596.2596
Published: 2005